Skip to main content
Toggle navigation
Search
Home
Health policy
Home
Health policy
Health policy
Type here to filter the list
(205) Income, Health and Racial Gaps Between 340B Hospitals, Child Sites, and Nearby Neighborhoods
(206) The timing and characteristics of supplemental indications for small and large molecule medicines
(207) Examining the Impact of Specialty Drug Rebates on Health Plan Coverage Decisions
(208) US Commercial health plan use of corticosteroids in step therapy protocols
(209) Does delaying coverage for accelerated approval treatments disproportionately impact patients with high unmet needs?
(210) Navigating artificial intelligence in evidence synthesis: A scoping review of current and developing guidelines
(211) Payer reactions to the Inflation Reduction Act and manufacturer financial assistance
(213) What evidence packages did CMS consider for Maximum Fair Price determination? A comparative analysis of Apixaban, Rivaroxaban and Sacubitril/Valsartan
(214) Factors associated with variation in drug costs in states with prescription drug affordability boards